UrgentRx

UrgentRx

Signal active

Organization

Contact Information

Overview

UrgentRx is a line of fast-acting, portable OTC medications providing right now relief and addressing the unmet needs of today’s busy, on-the-go consumer. UrgentRx Fast Powders come in an innovative, fast-acting flavored powder format available in convenient, single-dose, credit-card sized packets for easier portability and accessibility. The flavored powders can be taken without water, providing immediate relief whenever and wherever needed. Initially developed for heart attack victims, UrgentRx currently produces medications for everyday ailments such as headaches, aches and pains, allergies, heartburn, and upset stomach.

UrgentRx was founded in 2010 and is headquartered in Denver, Colorado, United States.

About

Industries

Health Care, Pharmaceutical, Medical

Founded

2010

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

UrgentRx headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $1.9B in funding across 72 round(s). With a team of 11-50 employees, UrgentRx is actively contributing to advancements in Health Care. Their latest funding round, Series A - UrgentRx, raised $1.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Michael J. Valentino

Michael J. Valentino

Chairman of the Board

imagePlace Genevieve Bucsek

Genevieve Bucsek

Chief Finance Officer

Funding Rounds

Funding rounds

6

Investors

0

Lead Investors

0

Total Funding Amount

$26.9M

Details

4

UrgentRx has raised a total of $26.9M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2014Late Stage Venture17.5M
2013Early Stage Venture2.7M
2012Early Stage Venture3.0M
2010Early Stage Venture1.6M

Investors

UrgentRx is funded by 5 investors.

Investor NameLead InvestorFunding RoundPartners
David Bonderman-FUNDING ROUND - David Bonderman17.5M
JUMP Investors-FUNDING ROUND - JUMP Investors17.5M
UrgentRx-FUNDING ROUND - UrgentRx17.5M
Boulevard Capital Partners-FUNDING ROUND - Boulevard Capital Partners17.5M

Recent Activity

There is no recent news or activity for this profile.